Advertisement

Topics

Centrexion Therapeutics Company Profile

12:18 EDT 23rd March 2017 | BioPortfolio

Centrexion Therapeutics, Inc., is focused on developing and commercializing new, non-opioid and non-surgical treatments for moderate to severe chronic pain. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and aims to develop new, safer and more effective therapies that overcome the limitations and challenges associated with current pain treatments. Founded by world-renowned leaders in drug development and well-funded by key investors, Centrexion Therapeutics is building a pain treatment powerhouse to address the substantial and growing global problem of chronic pain.


News Articles [1829 Associated News Articles listed on BioPortfolio]

Centrexion Therapeutics to Present at the 19th Annual BIO CEO & Investor Conference

Centrexion Therapeutics, a company focused on advancing the treatment of chronic pain with one of the largest exclusively pain-focused pipelines of non-opioid therapies in acti...

FDA fast-tracks Centrexion's Morton's neuroma treatment

Centrexion Therapeutics' CNTX-4975 received fast-track status from the FDA as a treatment for Morton's neuroma, a rare pain d -More- 

BRIEF-Centrexion Therapeutics announces fast track designation granted by FDA to cntx-4975

* Centrexion Therapeutics announces fast track designation granted by FDA to CNTX-4975 for treatment of Morton's Neuroma Source text for Eikon:

Centrexion's pain candidate passes Phase IIb test

Centrexion Therapeutics Corp. (Boston, Mass.) said pain candidate CNTX-4975 met the primary endpoint in a Phase IIb study to treat osteoarthritis (OA) knee pain. Compared with placebo, each of two tes...

Centrexion Therapeutics announces results from study on injection for relief of OA knee pain

Centrexion Therapeutics announced positive data from its phase 2b study of patients with knee osteoarthritis pain treated with CNTX-4975, the company’s lead pipeline candidate for pain reduction. Ac...

Centrexion Therapeutics Announces Highly Statistically Significant Topline Results from Phase ...

Pain Relief Occurred within Days, Lasted At Least Six Months from Single Injection Read more...

Centrexion Therapeutics to Present Data on CNTX-4975 from the Treatment of Knee Osteoarthritis Pain at IX SIMPAR-ISURA

Centrexion Therapeutics, a company focused on advancing the treatment of chronic pain with one of the largest exclusively pain-focused pipelines of non-opioid therapies in acti...

Centrexion Therapeutics to Present Late-Breaking Poster at the 33rd Annual American Academy of Pain Medicine Meeting

Company will present 12-week efficacy, safety and tolerability data from Phase 2b clinical trial of CNTX-4975 for treatment of osteoarthritis pain Centrexion Therapeuti...

Drugs and Medications [0 Results]

None

Clinical Trials [27 Associated Clinical Trials listed on BioPortfolio]

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Beat AML Core Study

In this study, DNA sequencing, computational biology modeling, and ex vivo drug sensitivity assays will be utilized to define clinically relevant gene mutations and identify potential ther...

Localized Therapeutics for the Treatment of Gastrointestinal Disorders II

The purpose of this study is to investigate a novel thermosensitive topical gel formulation for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis.

Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study

Prospective, single-arm, open label, Safety and Performance clinical investigation.

A Gene Transfer Study for Hemophilia A

This clinical research study is being conducted by Spark Therapeutics, Inc. to determine the safety and efficacy of the factor VIII gene transfer treatment with SPK-8011 in individuals wit...

Companies [1097 Associated Companies listed on BioPortfolio]

Centrexion Therapeutics, Corp.

Centrexion Therapeutics, Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-...

Centrexion Therapeutics

Centrexion Therapeutics, Inc., is focused on developing and commercializing new, non-opioid and non-surgical treatments for moderate to severe chronic pain. Centrexion Therapeutic...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Centrexion Therapeutics" on BioPortfolio

We have published hundreds of Centrexion Therapeutics news stories on BioPortfolio along with dozens of Centrexion Therapeutics Clinical Trials and PubMed Articles about Centrexion Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Centrexion Therapeutics Companies in our database. You can also find out about relevant Centrexion Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...


Corporate Database Quicklinks



Searches Linking to this Company Record